Exact Mass: 384.2777
Exact Mass Matches: 384.2777
Found 500 metabolites which its exact mass value is equals to given mass value 384.2777,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Megestil
CONFIDENCE standard compound; INTERNAL_ID 727; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9660; ORIGINAL_PRECURSOR_SCAN_NO 9655 CONFIDENCE standard compound; INTERNAL_ID 727; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9556; ORIGINAL_PRECURSOR_SCAN_NO 9555 CONFIDENCE standard compound; INTERNAL_ID 727; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9613; ORIGINAL_PRECURSOR_SCAN_NO 9611 CONFIDENCE standard compound; INTERNAL_ID 727; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9650; ORIGINAL_PRECURSOR_SCAN_NO 9648 CONFIDENCE standard compound; INTERNAL_ID 727; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9684; ORIGINAL_PRECURSOR_SCAN_NO 9681 CONFIDENCE standard compound; INTERNAL_ID 727; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9604; ORIGINAL_PRECURSOR_SCAN_NO 9603 D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants > D019167 - Appetite Stimulants C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone CONFIDENCE standard compound; INTERNAL_ID 2814 CONFIDENCE standard compound; INTERNAL_ID 8750 D000970 - Antineoplastic Agents
Bufogein
Bufogenin is a steroid lactone of Chan su (toad venom), a Chinese medicine obtained from the skin venom gland of toads. A specific Na/K-ATPase protein inhibitor, it is used as a cardiotonic and central nervous system (CNS) respiratory agent, an analgesic and anesthetic, and as a remedy for ulcers. It has a role as an EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor. It is a steroid lactone and an epoxy steroid. It is functionally related to a bufanolide. Resibufogenin is a natural product found in Sclerophrys mauritanica, Bufo gargarizans, and other organisms with data available. Bufogenin is a bufadienolide toxin originally isolated from the venom of the Chinese toad Bufo gargarizans; it is also one of the glycosides in the traditional Chinese medicine ChanSu, with potential cardiotonic activity. Although the mechanism of action of bufogenin is still under investigation, this agent is a specific Na+/K+-ATPase inhibitor and has been shown to reduce blood pressure in a rat model of preeclampsia. D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002018 - Bufanolides D002317 - Cardiovascular Agents C471 - Enzyme Inhibitor Resibufogenin is a component of cinobufogenin and has the function of inhibiting oxidative stress and tumor regeneration. Resibufogenin is a component of cinobufogenin and has the function of inhibiting oxidative stress and tumor regeneration.
Ibutilide
Ibutilide is only found in individuals that have used or taken this drug. It is a Class III antiarrhythmic agent that is indicated for acute cardioconversion of atrial fibrillation and atrial flutter of a recent onset to sinus rhythm. [Wikipedia]Ibutilide is a pure class III antiarrhythmic drug, used intravenously against atrial flutter and fibrillation. At a cellular level it exerts two main actions: induction of a persistent Na+ current sensitive to dihydropyridine Ca2+ channel blockers and potent inhibition of the cardiac rapid delayed rectifier K+ current, by binding within potassium channel pores. In other words, Ibutilide binds to and alters the activity of hERG potassium channels, delayed inward rectifier potassium (IKr) channels and L-type (dihydropyridine sensitive) calcium channels C - Cardiovascular system > C01 - Cardiac therapy > C01B - Antiarrhythmics, class i and iii > C01BD - Antiarrhythmics, class iii C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents C93038 - Cation Channel Blocker
Ethynodiol Diacetate
Ethynodiol Diacetate is only found in individuals that have used or taken this drug. It is a synthetic progestational hormone used alone or in combination with estrogens as an oral contraceptive. [PubChem]Binds to the progesterone and estrogen receptors. Target cells include the female reproductive tract, the mammary gland, the hypothalamus, and the pituitary. Once bound to the receptor, progestins like Ethynodiol Diacetate will slow the frequency of release of gonadotropin releasing hormone (GnRH) from the hypothalamus and blunt the pre-ovulatory LH (luteinizing hormone) surge. C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents Same as: D01294
ST 24:5;O4
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C483 - Therapeutic Estrogen D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones Same as: D01617 D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents Same as: D01294
Estra-1,3,5(10)-triene-3,16alpha-diol dipropionate
Acequinocyl
An acetate ester consisting of 1,4-naphthoquinone bearing acetoxy and dodecyl substituents at positions 2 and 3 respectively.
Tetrahydropersin
Tetrahydropersin is found in fruits. Tetrahydropersin is a constituent of avocado (Persea americana) Constituent of avocado (Persea americana). Tetrahydropersin is found in fruits.
Persicaxanthin
Persicaxanthin is found in european plum. Persicaxanthin is isolated from plums Prunus domestic Isolated from plums Prunus domestica. Persicaxanthin is found in fruits and european plum.
(-)-Pyrifolidine
(-)-Pyrifolidine is an alkaloid from Aspidosperma quebracho-blanco (quebracho). Alkaloid from Aspidosperma quebracho-blanco (quebracho).
Persicachrome
(3S,5R,8S)-Persicachrome is found in fruits. (3S,5R,8S)-Persicachrome is a constituent of flesh of cling peaches (Prunus persica). Constituent of flesh of cling peaches (Prunus persica). (3S,5R,8S)-Persicachrome is found in fruits.
MG(0:0/20:1(11Z)/0:0)
MG(0:0/20:1(11Z)/0:0) is a monoacylglyceride. A monoglyceride, more correctly known as a monoacylglycerol, is a glyceride consisting of one fatty acid chain covalently bonded to a glycerol molecule through an ester linkage. Monoacylglycerol can be broadly divided into two groups; 1-monoacylglycerols (or 3-monoacylglycerols) and 2-monoacylglycerols, depending on the position of the ester bond on the glycerol moiety. Normally the 1-/3-isomers are not distinguished from each other and are termed alpha-monoacylglycerols, while the 2-isomers are beta-monoacylglycerols. Monoacylglycerols are formed biochemically via release of a fatty acid from diacylglycerol by diacylglycerol lipase or hormone sensitive lipase. Monoacylglycerols are broken down by monoacylglycerol lipase. They tend to be minor components only of most plant and animal tissues, and indeed would not be expected to accumulate because their strong detergent properties would have a disruptive effect on membranes. 2-Monoacylglycerols are a major end product of the intestinal digestion of dietary fats in animals via the enzyme pancreatic lipase. They are taken up directly by the intestinal cells and converted to triacylglycerols via the monoacylglycerol pathway before being transported in lymph to the liver. Mono- and Diglycerides are commonly added to commercial food products in small quantities. They act as emulsifiers, helping to mix ingredients such as oil and water that would not otherwise blend well.
MG(20:1(11Z)/0:0/0:0)
MG(20:1(11Z)/0:0/0:0) is a monoacylglyceride. A monoglyceride, more correctly known as a monoacylglycerol, is a glyceride consisting of one fatty acid chain covalently bonded to a glycerol molecule through an ester linkage. Monoacylglycerol can be broadly divided into two groups; 1-monoacylglycerols (or 3-monoacylglycerols) and 2-monoacylglycerols, depending on the position of the ester bond on the glycerol moiety. Normally the 1-/3-isomers are not distinguished from each other and are termed alpha-monoacylglycerols, while the 2-isomers are beta-monoacylglycerols. Monoacylglycerols are formed biochemically via release of a fatty acid from diacylglycerol by diacylglycerol lipase or hormone sensitive lipase. Monoacylglycerols are broken down by monoacylglycerol lipase. They tend to be minor components only of most plant and animal tissues, and indeed would not be expected to accumulate because their strong detergent properties would have a disruptive effect on membranes. 2-Monoacylglycerols are a major end product of the intestinal digestion of dietary fats in animals via the enzyme pancreatic lipase. They are taken up directly by the intestinal cells and converted to triacylglycerols via the monoacylglycerol pathway before being transported in lymph to the liver. Mono- and Diglycerides are commonly added to commercial food products in small quantities. They act as emulsifiers, helping to mix ingredients such as oil and water that would not otherwise blend well.
N-Palmitoyl Glutamine
N-palmitoyl glutamine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Palmitic acid amide of Glutamine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Palmitoyl Glutamine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Palmitoyl Glutamine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.
N-Myristoyl Arginine
N-myristoyl arginine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Myristic acid amide of Arginine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Myristoyl Arginine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Myristoyl Arginine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.
7-[(1S,2R,3R,4R)-3-(3-Hydroxy-4-phenylpent-1-enyl)-7-oxabicyclo[2.2.1]heptan-2-yl]hept-5-enoic acid
4,4'-Bis(2-hydroxyethylethylamino)-2,2'-dimethylazobenzene
Bufogenin
D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002018 - Bufanolides D002317 - Cardiovascular Agents
Estradiol dipropionate
Estradiol enanthate
(Z)-3-(1,2-Dihydroxyethyl)-3-hydroxyhenicos-12-en-2-one
Zipeprol
R - Respiratory system > R05 - Cough and cold preparations > R05D - Cough suppressants, excl. combinations with expectorants C78273 - Agent Affecting Respiratory System > C66917 - Antitussive Agent D019141 - Respiratory System Agents > D000996 - Antitussive Agents D002491 - Central Nervous System Agents
5-hydroxy-4-isopropyl-1-methyl-7-(3-oxobutyl)bicyclo[4.1.0]hept-3-yl cinnamate
Decahydro-alpha,4a-dimethyl-8-methylene-7-(1-oxo-3-phenylpropoxy)-2-naphthaleneacetic acid
Epipolasinthiourea A
25-Hydroxy-13(24),15,17-cheilanthatrien-18,25-olide
5-[(Z)-12-(3,5-dihydroxyphenyl)dodec-8-enyl]benzene-1,3-diol
8-(4-Hydroxycinnamoyl)-(4beta,5alpha,8alpha)-1(10)-Guaiaene-8,11-diol|<4S,5S,7S,8S>-8-p-Coumaroyloxy-1(10)-guaien-11-ol|[4S,5S,7S,8S]-8-p-Coumaroyloxy-1(10)-guaien-11-ol
(1E,4S,5E,7R)-7-O-beta-D-glucopyranosylgermacra-1(10),5-diene
N-Methyl-N-(2,3,11a-trimethyl-2,3,3a,4,5,5a,5b,6,8,9,10,11,11a,11b,12,13-hexadecahydro-1H-2-aza-pentaleno[1,6a-a]phenanthren-9-yl)-acetamide
plakortolide Q
An organic heterobicyclic compound that is a cyclic peroxy compound isolated from the Australian marine sponge Plakinastrella clathrata.
(3beta,22E)-3-Hydroxy-24-norcholesta-5,22-dien-7-one
5alpha,6alpha-epoxy-26,27-dinorergosta-7,22(E)-dien-3beta-ol
(16S)-23,24,25,26,27-pentanorcycloartan-3-one-16,22-olide|(5alpha,16beta,20S)-23,24,25,26,27-Pentanor-3-oxocycloartan-22,16-olide
3-(Dimethylamino)pregna-14,16-dien-20-yl(methyl)formamide
isobutyl 13-(1,3-benzdioxolo-5)trideca-2E,4E,12E-trienoate
3beta,16beta-dihydroxy-bufa-8(14),20,22-trienolide
(20S)-3beta-N-methyl-20-(N-acetyl-N-methylamino)-pregna-5,14-diene
(10S)-3c,8c,12c,14c,17c-Pentahydroxy-10r,13c-dimethyl-17t-((Xi)-1-hydroxy-aethyl)-(5tH,9tH)-hexadecahydro-1H-cyclopenta[a]phenanthren|(3?,5?,12?,14?,17S,20R)-Pregnane-3,8,12,14,17,20-hexol|3beta,8beta,12beta,14,17beta-Pentahydroxy-10,13-dimethyl-17alpha-((Xi)-1-hydroxy-aethyl)-5alpha,14beta-gonan|5alpha,14beta,17betaH-Pregnanhexol-(3beta,8,12beta,14,17,20xi)|5alpha-Dihydrosarcostin|diginanehexol-(3beta,8,12beta,14,17,20xi)|Diginanhexol-(3beta,8,12beta,14,17,20xi)|Dihydrosarcostin
(2R*,5S*,7S*,10S*)-10-methyl-2-[(1-methyl-1-beta-D-fucopyranosyloxy)ethyl]-6-methylenespiro[4.5]decan-7-ol
3-oxo-choladien-(1.4)-oic acid-(24)-methyl ester|3-Oxo-choladien-(1.4)-saeure-(24)-methylester|choladiene-1,4 one-3 oate-24 de methyle|methyl 3-oxochola-1,4-dien-24-oate
(3beta,22E)-3-Hydroxy-26,27-dinorcholesta-5,22-diene-7,24-dione
23,6alpha-epoxy-labd-8,13(14),17-trien-16(R),19-olide
(3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl) heptanoate
Me ester,di-Ac-(7S,8Z)-7,16-Dihydroxy-8-hexadecenoic acid
(23E)-3beta-hydroxy-27-norcholesta-5,23-dien-25-one
7-oxo-chola-3,5-dien-24-oic acid methyl ester|7-Oxo-chola-3,5-dien-24-saeure-methylester|methyl 7-oxochola-3,5-dien-24-oate
[4,5-dihydroxy-3,4-bis(hydroxymethyl)-4a,8,8-trimethyl-5,6,7,8a-tetrahydro-1H-naphthalen-1-yl] hexanoate
[4,5-dihydroxy-3,4-bis(hydroxymethyl)-4a,8,8-trimethyl-5,6,7,8a-tetrahydro-1H-naphthalen-1-yl] hexanoate
Zipeprol
R - Respiratory system > R05 - Cough and cold preparations > R05D - Cough suppressants, excl. combinations with expectorants C78273 - Agent Affecting Respiratory System > C66917 - Antitussive Agent D019141 - Respiratory System Agents > D000996 - Antitussive Agents D002491 - Central Nervous System Agents
[4,5-dihydroxy-3,4-bis(hydroxymethyl)-4a,8,8-trimethyl-5,6,7,8a-tetrahydro-1H-naphthalen-1-yl] hexanoate_99.4\\%
[4,5-dihydroxy-3,4-bis(hydroxymethyl)-4a,8,8-trimethyl-5,6,7,8a-tetrahydro-1H-naphthalen-1-yl] hexanoate_major
[4,5-dihydroxy-3,4-bis(hydroxymethyl)-4a,8,8-trimethyl-5,6,7,8a-tetrahydro-1H-naphthalen-1-yl] hexanoate_84.2\\%
Ala Pro Val Val
Ala Val Pro Val
Ala Val Val Pro
Gly Ile Pro Val
Gly Ile Val Pro
Gly Leu Pro Val
Gly Leu Val Pro
Gly Pro Ile Val
Gly Pro Leu Val
Gly Pro Val Ile
Gly Pro Val Leu
Gly Val Ile Pro
Gly Val Leu Pro
Gly Val Pro Ile
Gly Val Pro Leu
Ile Gly Pro Val
Ile Gly Val Pro
Ile Pro Gly Val
Ile Pro Val Gly
Ile Val Gly Pro
Ile Val Pro Gly
Leu Gly Pro Val
Leu Gly Val Pro
Leu Pro Gly Val
Leu Pro Val Gly
Leu Val Gly Pro
Leu Val Pro Gly
Pro Ala Val Val
Pro Gly Ile Val
Pro Gly Leu Val
Pro Gly Val Ile
Pro Gly Val Leu
Pro Ile Gly Val
Pro Ile Val Gly
Pro Leu Gly Val
Pro Leu Val Gly
Pro Val Ala Val
Pro Val Gly Ile
Pro Val Gly Leu
Pro Val Ile Gly
Pro Val Leu Gly
Pro Val Val Ala
Val Ala Pro Val
Val Ala Val Pro
Val Gly Ile Pro
Val Gly Leu Pro
Val Gly Pro Ile
Val Gly Pro Leu
Val Ile Gly Pro
Val Ile Pro Gly
Val Leu Gly Pro
Val Leu Pro Gly
Val Pro Ala Val
Val Pro Gly Ile
Val Pro Gly Leu
Val Pro Ile Gly
Val Pro Leu Gly
Val Pro Val Ala
Val Val Ala Pro
Val Val Pro Ala
(-)-Pyrifolidine
Persicaxanthin
Persicachrome
4,5-Dihydroxy-3,4-bis(hydroxymethyl)-4a,8,8-trimethyl-1,4,4a,5,6,7,8,8a-octahydro-1-naphthalenyl hexanoate
DICYCLOHEXYLAMINE (R)-3-((TERT-BUTOXYCARBONYL)AMINO)-2-METHYLPROPANOATE
TRIMETHYL CIS,CIS-1,3,5-TRIPROPYL-1,3,5-CYCLOHEXANETRICARBOXYLATE
Pyrimidine, 2-[4-[1-(1-cyclohexyl-1H-tetrazol-5-yl)-3-methylbutyl]-1-piperazinyl]- (9CI)
[2-(5-Carboxypentyl)-4,4-dimethyl-2-undecyl-1,3-oxazolidin-3-yl]o xidanyl
[(1S,3S,4S)-4-Amino-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]carbamic acid 1,1-dimethylethyl ester
tert-butyl 4-(2-oxospiro[cyclohexane-1,3-indole]-1-yl)piperidine-1-carboxylate
butyl prop-2-enoate,6-methylheptyl prop-2-enoate,prop-2-enoic acid
1-(2,6-Diisopropylphenyl)-3-(2,4,6-trimethylphenyl)-4,5-dihydroimidazolium chloride
Estradiol enanthate
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D004967 - Estrogens C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C483 - Therapeutic Estrogen
[4-(4-propylcyclohexyl)phenyl] 4-butylcyclohexane-1-carboxylate
(2R)-2-cyclopentyl-2-hydroxy-N-[1-(4-methylpent-3-enyl)-4-piperidinyl]-2-phenylacetamide
(S)-N-(4-Carbamimidoylbenzyl)-1-(3-Cyclohexylpropanoyl)pyrrolidine-2-Carboxamide
Butyl [2-cyclohexyl-6-(pyrrolidin-1-yl)-1H-benzimidazol-5-yl]carbamate
4,4'-Bis(2-hydroxyethylethylamino)-2,2'-dimethylazobenzene
[3-carboxy-2-[(E)-pentadec-9-enoyl]oxypropyl]-trimethylazanium
(Z)-3-(1,2-Dihydroxyethyl)-3-hydroxyhenicos-12-en-2-one
4-(4,4-Dimethyl-3-oxido-2-tridecyl-1,3-oxazolidin-2-yl)butanoic acid
[3-carboxy-2-[(5Z,8Z)-3-hydroxytetradeca-5,8-dienoyl]oxypropyl]-trimethylazanium
[(2R)-3-carboxy-2-[(3R,5Z,8Z)-3-hydroxytetradeca-5,8-dienoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(8E,11E)-6-hydroxytetradeca-8,11-dienoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(9E,11E)-7-hydroxytetradeca-9,11-dienoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(8E,10E)-6-hydroxytetradeca-8,10-dienoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(7E,9E)-5-hydroxytetradeca-7,9-dienoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(8E,11E)-5-hydroxytetradeca-8,11-dienoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(6E,8E)-4-hydroxytetradeca-6,8-dienoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(6E,9E)-3-hydroxytetradeca-6,9-dienoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(7E,10E)-4-hydroxytetradeca-7,10-dienoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(10E,12E)-4-hydroxytetradeca-10,12-dienoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(9E,12E)-6-hydroxytetradeca-9,12-dienoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(10E,12E)-8-hydroxytetradeca-10,12-dienoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(5E,7E)-3-hydroxytetradeca-5,7-dienoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(4E,6E)-2-hydroxytetradeca-4,6-dienoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(E)-pentadec-10-enoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(E)-pentadec-2-enoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(E)-pentadec-7-enoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(E)-pentadec-6-enoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(E)-pentadec-5-enoyl]oxypropyl]-trimethylazanium
(6aR,10aR)-1-methoxy-6,6,9-trimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene
rel-(2R,5S,7S,10S)-10-Methyl-2-[(1-methyl-1-beta-D-fucopyranosyloxy)ethyl]-6-methylenespiro[4.5]decan-7-ol
A natural product found in Carthamus oxyacantha and Carduncellus mareoticus.
N-tert-butyl-2-[2-ethoxy-4-[(2-phenylethylamino)methyl]phenoxy]acetamide
N-[[(2R,3S,4S)-1-acetyl-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-N-methylpropanamide
N-[[(2S,3R,4R)-1-acetyl-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-N-methylpropanamide
2-cyclopropyl-1-[(2R,3S)-2-(hydroxymethyl)-1-(4-oxanylmethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]ethanone
dihydrostemphyloxin I
An octahydronaphthalene that is stemphyloxin I in which the C=C bond of the enol moiety has been reduced to a C-C bond.
2-[2-(2,5-dimethyl-1-phenylpyrrol-3-yl)ethyl]-N,N,1-trimethylquinolin-1-ium-6-amine
[(1S)-3-carboxy-1-[(5E,7E)-3-hydroxytetradeca-5,7-dienoyl]oxypropyl]-trimethylazanium
(2R)-1-(dimethylamino)-2-[4-[(4-methoxy-3-methylphenyl)methyl]-3,5-dihydro-2H-1,4-benzoxazepin-7-yl]propan-2-ol
[1-[(Z)-heptadec-9-enoxy]-3-hydroxypropan-2-yl] propanoate
[1-hydroxy-3-[(Z)-pentadec-9-enoxy]propan-2-yl] pentanoate
[1-hydroxy-3-[(Z)-tetradec-9-enoxy]propan-2-yl] hexanoate
[1-hydroxy-3-[(Z)-tridec-9-enoxy]propan-2-yl] heptanoate
[1-[(Z)-hexadec-9-enoxy]-3-hydroxypropan-2-yl] butanoate
(1-hexanoyloxy-3-hydroxypropan-2-yl) (Z)-tridec-9-enoate
(1-hydroxy-3-pentanoyloxypropan-2-yl) (Z)-tetradec-9-enoate
(1-acetyloxy-3-hydroxypropan-2-yl) (Z)-heptadec-9-enoate
(1-hydroxy-3-propanoyloxypropan-2-yl) (Z)-hexadec-9-enoate
(1-butanoyloxy-3-hydroxypropan-2-yl) (Z)-pentadec-9-enoate
2-[Hydroxy-(2-hydroxy-3-nonoxypropoxy)phosphoryl]oxyethyl-trimethylazanium
Ibutilide
C - Cardiovascular system > C01 - Cardiac therapy > C01B - Antiarrhythmics, class i and iii > C01BD - Antiarrhythmics, class iii C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents C93038 - Cation Channel Blocker
8Z,11Z,14Z,17Z,20Z,23Z-hexacosahexaenoic acid
A very long-chain omega-3 fatty acid that is hexacosanoic acid having six double bonds located at positions 8, 11, 14, 17, 20, 23 (the 8Z,11Z,14Z,17Z,20Z,23Z-isomer).
